Skip to main content

Advertisement

Table 1 Patient's clinical data.

From: MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis

Patient Number Age Sex Localization T stage N stage Metastasis Clinical stage Tumor differentiation
1 52 M Larynx 1 0 0 I Poorly
2 98 M Larynx 1 0 0 I Well
3 73 M Larynx 1 0 0 I Well
4 57 M Oral cavity 2 0 0 II Poorly
5 65 F Larynx 2 0 0 II Well
6 68 M Oral cavity 2 0 0 II Well
7 64 F Oral cavity 2 0 0 II Well
8 63 M Pharynx 2 0 0 II Well
9 50 M Oral cavity 2 1 0 III Moderately
10 64 M Larynx 3 1 0 III Well
11 48 F Oral cavity 3 1 0 III Poorly
12 47 F Oral cavity 3 1 0 III Well
13 77 M Oral cavity 3 1 0 III Poorly
14 59 M Oral cavity 3 1 0 III Well
15 69 F Oral cavity 3 0 0 III Well
16 56 M Larynx 3 0 0 III Moderately
17 65 M Oral cavity 3 0 0 III Well
18 40 F Oral cavity 3 0 0 III Poorly
19 56 M Pharynx 3 0 0 III Poorly
20 70 M Larynx 3 0 0 III Moderately
21 75 M Pharynx 3 0 0 III Well
22 65 M Oral cavity 3 1 0 III Well
23 60 F Oral cavity 2 1 0 III Moderately
24 56 M Pharynx 4 0 0 IVA Moderately
25 54 F Pharynx 4 0 0 IVA Poorly
26 55 M Oral cavity 4 2 0 IVA Moderately
27 65 M Pharynx 4 2 0 IVA Moderately
28 58 M Larynx 4 0 0 IVA Poorly
29 53 M Larynx 4 0 0 IVA Moderately
30 62 M Oral cavity 4 2 0 IVA ND
31 29 F Oral cavity 3 2 0 IVA Moderately
32 60 F Oral cavity 3 2 0 IVA Well
33 38 M Pharynx 4 1 0 IVA Poorly
34 62 F Larynx 1 2 0 IVA Moderately
35 68 M Larynx 3 2 0 IVA Moderately
36 68 M Oral cavity 4 1 0 IVA Moderately
37 50 M Oral cavity 3 2 0 IVA Poorly
38 61 F Pharynx 2 2 0 IVA Poorly
39 62 M Larynx 3 2 0 IVA Poorly
40 53 M Larynx 4 2 0 IVA Well
41 84 F Larynx 4 0 0 IVA Well
42 50 M Oral cavity 4 0 0 IVA Poorly
43 55 M Oral cavity 4 0 0 IVA Moderately
44 73 F Oral cavity 4 1 0 IVA Poorly
45 71 M Oral cavity 4 0 0 IVA Moderately
46 49 M Oral cavity 4 0 0 IVA Well
47 54 M Oral cavity 4 2 0 IVA Poorly
48 72 M Pharynx 4 1 0 IVA Moderately
49 59 M Larynx 4 2 0 IVA Moderately
50 68 M Larynx 4 3 0 IVB Moderately
51 54 M Larynx 3 3 0 IVB Moderately
52 61 M Pharynx 4 3 0 IVB Moderately
53 72 M Oral cavity 3 3 1 IVC Well
  1. Site, sex, clinical stage, T and N stage and tumor differentiation are included.